US 8889831
Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypeptide conjugate
granted A61KA61K38/37A61K47/10
Quick answer
US patent 8889831 (Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypeptide conjugate) held by Nektar Therapeutics expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K38/37, A61K47/10, A61K47/60, A61P